The Economics of Near Patient Testing
It is always difficult, in addressing an international meeting such as this on laboratory management and economics, to distinguish the fundamentals — which hold true wherever one is practicing — from those that depend largely, or wholly, upon local factors such as methods and modes of payment for medical care, educational standards of the doctors and expectations of their patients, the availability of equipment, reagents and the expertise to use them, even the geography and climate.
KeywordsClinical Laboratory Clinical Biochemistry Hospital Laboratory Clinical Laboratory Test Capital Equipment
Unable to display preview. Download preview PDF.
- 1.J.N. Nabarro, “Biochemical Investigations in Diagnosis and Treatment, H.K. Lewis, London (1954).Google Scholar
- 5.J. Landauer, Blood tests to go, Med. World News 13: 23 (1987).Google Scholar
- 6.V. Marks, Clinical Biochemistry: Trade and profession, University of Surrey, Guildford (1972).Google Scholar
- 7.V. Marks, The choice between discretionary and profile testing, in: “Centrifugal Analysers in Clinical Chemistry”, C.P. Price and K. Spencer, eds., Praeger, Eastbourne (1980).Google Scholar
- 10.V. Marks, Who should investigate patients, Bull, R.C. Path. 42: 2 (1983).Google Scholar
- 15.V. Marks, Therapeutic drug monitoring,in: “Clinical Biochemistry Nearer the Patient”, V. Marks and K.G.M. Alberti, eds., Churchill Livingstone, Edinburgh (1985).Google Scholar
- 16.L.H. Bernstein, Decentralized testing: cost implications and benefits, in: “Clinical Biochemistry Nearer the Patient II”, V. Marks and K.G.M.M. Alberti, eds., Balliere Tindall, London (1986).Google Scholar
- 17.T.M. Craig, The economics of near-patient testing, in: “Clinical Biochemistry Nearer the Patient II”, V. Marks and K.G.M.M. Alberti, eds., Balliere Tindall, London (1986).Google Scholar